Renaissance Technologies’s Hepion Pharmaceuticals HEPA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-347
| Closed | -$8.16K | – | 3608 |
|
2024
Q4 | $8.16K | Buy |
347
+16
| +5% | +$376 | ﹤0.01% | 3526 |
|
2024
Q3 | $11.1K | Buy |
+331
| New | +$11.1K | ﹤0.01% | 3455 |
|
2023
Q3 | – | Sell |
-267
| Closed | -$140K | – | 3838 |
|
2023
Q2 | $140K | Sell |
267
-17
| -6% | -$8.91K | ﹤0.01% | 3391 |
|
2023
Q1 | $221K | Buy |
284
+38
| +15% | +$29.6K | ﹤0.01% | 3236 |
|
2022
Q4 | $74K | Buy |
246
+14
| +6% | +$4.21K | ﹤0.01% | 3702 |
|
2022
Q3 | $117K | Sell |
232
-3
| -1% | -$1.51K | ﹤0.01% | 3541 |
|
2022
Q2 | $134K | Buy |
235
+108
| +85% | +$61.6K | ﹤0.01% | 3767 |
|
2022
Q1 | $163K | Buy |
127
+77
| +154% | +$98.8K | ﹤0.01% | 3697 |
|
2021
Q4 | $57K | Buy |
+50
| New | +$57K | ﹤0.01% | 3769 |
|
2021
Q2 | – | Sell |
-158
| Closed | -$290K | – | 3592 |
|
2021
Q1 | $290K | Sell |
158
-171
| -52% | -$314K | ﹤0.01% | 3063 |
|
2020
Q4 | $721K | Buy |
+329
| New | +$721K | ﹤0.01% | 2664 |
|
2020
Q1 | – | Sell |
-43
| Closed | -$231K | – | 3578 |
|
2019
Q4 | $231K | Buy |
+43
| New | +$231K | ﹤0.01% | 3156 |
|
2019
Q3 | – | Sell |
-10
| Closed | -$43K | – | 3532 |
|
2019
Q2 | $43K | Buy |
+10
| New | +$43K | ﹤0.01% | 3465 |
|